Scientists discover possible way to turn fungus from foe to friend

September 24, 2013
When it enters the bloodstream, the normally harmless fungus Candida albicans can form extensions called hyphae in order to penetrate host tissue (left). On right, hyphae (green) invade intestinal cells (red, with nuclei stained blue). Credit: Rajini Rao

Candida albicans is a double agent: In most of us, it lives peacefully, but for people whose immune systems are compromised by HIV or other severe illnesses, it is frequently deadly. Now a new study from Johns Hopkins and Harvard Medical School shows how targeting a specific fungal component might turn the fungus from a lion back into a kitten. Study results were reported this month in The Journal of Biological Chemistry.

"Treatment options for systemic Candida infections are limited, and a major difficulty in finding new is that fungi are closely related to us, so we risk hurting the patient as much as the pathogen," says Rajini Rao, Ph.D., a professor of physiology in the Institute for Basic Biomedical Sciences at the Johns Hopkins University School of Medicine. "What we've identified is a function that is critical for virulence. If we could block this through medication, it would leave both the fungus and the host healthy while taking away Candida's ability to harm." Candida lives in the guts of most people as one of many so-called "commensal microbes"—that is, harmlessly. It can sometimes cause local infections of the mouth or genitals, known as thrush, that are treatable with over-the-counter . But given the opportunity to breach our defenses, Candida can cross into the bloodstream and switch from peaceful coexistence to attack mode, producing long that dig into tissues and destroy them.

Unfortunately, Rao says, "there are only a few , so it's particularly dangerous when develops in Candida." For that reason, she says, "we're always looking for new chinks in its armor."

In her study, Rao and her collaborators looked for such a new chink in a part of Candida's cells known as the vacuole. The vacuole's main function is as a recycling center that chews up cellular waste, so it was a surprise when a previous study from her group found that a well-known antifungal drug prevented the vacuole from becoming acidic. This led them to suspect that acidification of the vacuole was important for virulence. The research team focused on V-ATPase, the enzyme responsible for making many compartments of the cell, including the vacuoles, acidic. Because humans have a very similar enzyme, the scientists weren't looking to eliminate it altogether—"that would have been like taking a sledgehammer to cells," Rao explains. Rather, they homed in on just one of the enzyme's components, known as subunit a. Like many proteins in fungi and higher animals, there is more than one version of subunit a, which come from different genes—a duplication that gives the organism a backup in case a mutation disables one of the genes.

Rao said first they altered Candida cells so that they could only use one or the other version of the subunit a gene. As expected, they found that inactivating either one had no effect because the other compensates in every function—except one. It turned out that acidification of the vacuole exclusively depended on one version of the gene. This allowed them to test the importance of the vacuole's acidity on , separate from the many other functions of the V-ATPase. Unable to acidify the vacuole, the fungus could no longer form the tentacle-like filaments that characterize its deadly form. When the researchers injected healthy Candida into the bloodstream of mice, nearly all died within a week. In contrast, mice injected with the strain of fungus that was unable to acidify the vacuole remained healthy and survived.

Rao says that this study reveals a vulnerability that could be exploited using drugs known to alter the pH of the vacuole, rendering Candida harmless while potentially posing little risk to infected patients. For example, previous studies from her lab showed that a drug already in use to treat a heart condition known as arrhythmia had the unexpected effect of blocking acidification of the fungal vacuole. The next step, she says, would be to screen drugs already approved by the U. S. Food and Drug Administration to increase the repertoire of antifungal agents to combat deadly fungal infections.

Explore further: Research treats the fungus among us with nontoxic medicinal compound

More information:

Related Stories

Fatal fungal infections resist newest class of drugs

September 7, 2011

Fungi that cause severe infections in those with compromised immune systems are resisting the action of the latest group of antifungal drugs. Uncovering their strategies for doing this will lead to more effective treatments, ...

Research identifies how mouth cells resist Candida infection

September 2, 2013

Candida albicans is a common fungus found living in, and on, many parts of the human body. Usually this species causes no harm to humans unless it can breach the body's immune defences, where can lead to serious illness or ...

New compound prevents first steps of fungal infection

August 13, 2013

Targeting serious and sometimes deadly fungal infections, a team of researchers at Worcester Polytechnic Institute (WPI) and the University of Massachusetts Medical School (UMMS) has discovered a chemical compound that prevents ...

How a common fungus knows when to attack

July 24, 2012

The opportunistic fungal pathogen Candida albicans inconspicuously lives in our bodies until it senses that we are weak, when it quickly adapts to go on the offensive. The fungus, known for causing yeast and other minor infections, ...

Recommended for you

Close up view of growing polymer chain show jump steps

October 20, 2017

(—A team of researchers at Cornell University has devised a means for watching as a polymer chain grows after application of a catalyst. In their paper published in the journal Science, the team explains how they ...

The birth of a new protein

October 20, 2017

A yeast protein that evolved from scratch can fold into a three-dimensional shape—contrary to the general understanding of young proteins—according to new research led by the University of Arizona.

Discovery lights path for Alzheimer's research

October 19, 2017

A probe invented at Rice University that lights up when it binds to a misfolded amyloid beta peptide—the kind suspected of causing Alzheimer's disease—has identified a specific binding site on the protein that could facilitate ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Sep 24, 2013
Re:"a drug already in use to treat a heart condition known as arrhythmia had the unexpected effect of blocking acidification of the fungal vacuole. "


Gamarra S, Rocha EM, Zhang YQ, Park S, Rao R, Perlin DS (2010) Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans. Antimicrob Agents Chemother. 54(5):1753-61.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.